- Home
- Equipment
- australasia
- chemotherapy
Show results for
Refine by
Chemotherapy Equipment Supplied In Australasia
7 equipment items found
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® docetaxel is an enhanced version of docetaxel (Taxotere®) – widely used for breast, lung & prostate cancer. Docetaxel (Taxotere®) is a commonly used chemotherapy agent despite having multiple US FDA “Black Box” warnings. DEP® docetaxel is a detergent free, aqueous formulation of docetaxel. ...
Manufactured by:ICU Medical, Inc. based inSan Clemente, CALIFORNIA (USA)
Treating cancer patients takes compassion—it shouldn’t take a toll on your health. But the fact is, while chemotherapy is the backbone of medical oncology, these powerful medications—along with many others—are extremely toxic to the clinicians who handle them. Prolonged exposure to hazardous drug vapors, drips, or spills has been shown to lead to hair ...
Manufactured by:Camurus AB based inLund, SWEDEN
Camurus' clinical pipeline represents a healthy mix of in-house and partnered programs from early to late stage development. Our innovative product candidates are designed to address important unmet medical needs, with the potential to make a significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term ...
Manufactured by:Camurus AB based inLund, SWEDEN
episil® oral liquid is a medical device for treatment of inflammatory and painful conditions in the oral cavity. The product provides fast pain relief and protection of sore and inflamed mucosal surfaces, as well as severe inflammation caused by e.g. oral mucositis, a common and serious side effect of cancer treatment. In contact with the buccal membrane, episil® transforms into a thin ...
by:Carina Biotech based inMawson Lakes, AUSTRALIA
Advanced colorectal cancer currently has a poor prognosis and is the deadliest form of cancer for Australians 25 to 34 years old. LGR5 is a cancer stem cell marker that is highly expressed on advanced colorectal cancer and other cancers. In colon cancer patients, LGR5+ expression has been correlated with a particularly poor ...
by:Bonalive Biomaterials Ltd based inTurku, FINLAND
Bonalive putty MIS is a smart bone regeneration technology, providing stable positioning and controlled access in minimally invasive ...
by:AdAlta Limited based inBundoora, AUSTRALIA
AdAlta and Carina Biotech to develop next-generation i-body enabled CAR-T cancer therapeutics. AdAlta has entered a collaboration agreement with Carina Biotech to develop next-generation i-body enabled CAR-T cells, with the potential to bring CAR-T cell therapy to treat a far greater range of cancers than the small number of blood cancers that has been achieved today. Under the Collaboration ...